TriSalus outlines 50% revenue growth target for 2025 while advancing TriNav platform and streamlining costs
Source: SeekingAlpha
2025-08-12 20:54:05 ET
More on TriSalus Life Sciences
- TriSalus Life Sciences, Inc. (TLSI) Q2 2025 Earnings Call Transcript
- TriSalus Life Sciences, Inc. (TLSI) Q1 2025 Earnings Conference Call Transcript
- TriSalus Life Sciences GAAP EPS of $0.27 beats by $0.48, revenue of $11.2M beats by $0.51M
- TriSalus Life Sciences launches preferred stock exchange
- Seeking Alpha’s Quant Rating on TriSalus Life Sciences
Read the full article on Seeking Alpha
For further details see:
TriSalus outlines 50% revenue growth target for 2025 while advancing TriNav platform and streamlining costs
TriSalus Life Sciences Inc. Warrant
NASDAQ: TLSIW
TLSIW Trading
-1.27% G/L:
$1.56 Last:
1,306 Volume:
$1.58 Open:
TLSIW Latest News
TLSIW Stock Data
$218,310,730
36,224,125
N/A
18
N/A
Medical Equipment & Supplies
Healthcare
US
Westminster
